Tom 6, Nr 3 (2021)
Artykuł przeglądowy
Opublikowany online: 2021-06-09

dostęp otwarty

Wyświetlenia strony 165
Wyświetlenia/pobrania artykułu 106
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Treatment of rectal cancer in the older population

Jakub Kenig1
Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory 2021;6(3):214-217.


The majority of rectal cancer patients are elderly. Biological age, not chronological age alone, is the main risk factor of postoperative morbidity in this group. Therefore, based on the Comprehensive Geriatric Assessment, we can differentiate three groups of patients: fit, pre-frail and frail. In the fit group, a standard multimodal oncologic treatment can be offered. In the pre-frail group, prerehabilitation should be recommended to improved resilience to surgical stress. In frail patients, a tailored approach should be discussed in a geriatric multidisciplinary team meeting. At present, a whole range of multimodal tailored approaches can be offered to rectal cancer patients. In this group, of much more importance is postoperative functional recovery, including both organ-specific outcomes and the ability to regain independence than currently used outcome indicators. Therefore, as important as cancer staging and tumour biology, it is crucial to understand the health status of an older patient with rectal cancer.

Artykuł dostępny w formacie PDF

Pokaż PDF (angielski) Pobierz plik PDF


  1. Smith BD, Smith GL, Hurria A, et al. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009; 27(17): 2758–2765.
  2. Abbasi J. Older Patients (Still) Left Out of Cancer Clinical Trials. JAMA. 2019; 322(18): 1751–1753.
  3. Schiphorst AHW, Pronk A, Borel Rinkes IHM, et al. Representation of the elderly in trials of laparoscopic surgery for colorectal cancer. Colorectal Dis. 2014; 16(12): 976–983.
  4. Lawler M, Selby P, Aapro MS, et al. Ageism in cancer care. BMJ. 2014; 348(feb28 1): g1614–g1614.
  5. Montroni I, Ugolini G, Saur NM, et al. Personalized management of elderly patients with rectal cancer: Expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Surgeons Commission on Cancer. Eur J Surg Oncol. 2018; 44(11): 1685–1702.
  6. Tomasz G, Kenig J. Problemy okołooperacyjne u osób w wieku podeszłym. PZWL Wydawnictwo Lekarskie 2018.
  7. Glynne-Jones R, Wyrwicz L, Tiret E, et al. ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017; 28(suppl_4): iv22–iv40.
  8. Saur NM, Montroni I, Shahrokni A, et al. Care of the Geriatric Colorectal Surgical Patient and Framework for Creating a Geriatric Program: A Compendium From the 2019 American Society of Colon and Rectal Surgeons Annual Meeting. Dis Colon Rectum. 2020; 63(11): 1489–1495.
  9. NICE guideline Published: 29 January 2020.
  10. Kenig J. Oncogeriatrics (part 4.) Pre-operative assessment of elderly patients with cancer. Nowotwory. Journal of Oncology. 2020; 70(1): 16–19.
  11. Kenig J. Oncogeriatrics (part 1.). Frailty in older adults with cancer. Nowotwory. Journal of Oncology. 2019; 69(2): 55–57.
  12. Xue DD, Cheng Y, Wu M, et al. Comprehensive geriatric assessment prediction of postoperative complications in gastrointestinal cancer patients: a meta-analysis. Clin Interv Aging. 2018; 13: 723–736.
  13. Perez RO, Habr-Gama A, São Julião GP, et al. Transanal endoscopic microsurgery for residual rectal cancer after neoadjuvant chemoradiation therapy is associated with significant immediate pain and hospital readmission rates. Dis Colon Rectum. 2011; 54(5): 545–551.
  14. Borstlap WAA, Coeymans TJ, Tanis PJ, et al. Meta-analysis of oncological outcomes after local excision of pT1-2 rectal cancer requiring adjuvant (chemo)radiotherapy or completion surgery. Br J Surg. 2016; 103(9): 1105–1116.
  15. Rutten HJT, den Dulk M, Lemmens VE, et al. Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol. 2008; 9(5): 494–501.
  16. Bonjer HJ, Deijen CL, Abis GA, et al. COLOR II Study Group. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med. 2015; 372(14): 1324–1332.
  17. Guillou P, Quirke P, Thorpe H, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. The Lancet. 2005; 365(9472): 1718–1726.
  18. Nelson H, Sargent DJ, Wieand HS, et al. Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004; 350(20): 2050–2059.
  19. Li Y, Wang S, Gao S, et al. Laparoscopic colorectal resection versus open colorectal resection in octogenarians: a systematic review and meta-analysis of safety and efficacy. Tech Coloproctol. 2016; 20(3): 153–162.
  20. Senagore AJ, Madbouly KM, Fazio VW, et al. Advantages of laparoscopic colectomy in older patients. Arch Surg. 2003; 138(3): 252–256.
  21. Hamaker ME, Schiphorst AH, Verweij NM, et al. Improved survival for older patients undergoing surgery for colorectal cancer between 2008 and 2011. Int J Colorectal Dis. 2014; 29(10): 1231–1236.
  22. Jayne D, Pigazzi A, Marshall H, et al. Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial. JAMA. 2017; 318(16): 1569–1580.
  23. Ceccarelli G, Andolfi E, Biancafarina A, et al. Robot-assisted surgery in elderly and very elderly population: our experience in oncologic and general surgery with literature review. Aging Clin Exp Res. 2017; 29(Suppl 1): 55–63.
  24. de'Angelis N, Abdalla S, Bianchi G, et al. Robotic Versus Laparoscopic Colorectal Cancer Surgery in Elderly Patients: A Propensity Score Match Analysis. J Laparoendosc Adv Surg Tech A. 2018; 28(11): 1334–1345.
  25. Habr-Gama A, Sabbaga J, Gama-Rodrigues J, et al. Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? Dis Colon Rectum. 2013; 56(10): 1109–1117.
  26. Smith FM, Rao C, Oliva Perez R, et al. Avoiding radical surgery improves early survival in elderly patients with rectal cancer, demonstrating complete clinical response after neoadjuvant therapy: results of a decision-analytic model. Dis Colon Rectum. 2015; 58(2): 159–171.
  27. Beets GL, Figueiredo NL, Habr-Gama A, et al. A new paradigm for rectal cancer: Organ preservation: Introducing the International Watch & Wait Database (IWWD). Eur J Surg Oncol. 2015; 41(12): 1562–1564.
  28. Breugom A, Swets M, Bosset JF, et al. Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data. The Lancet Oncology. 2015; 16(2): 200–207.
  29. Bujko K, Glimelius B, Valentini V, et al. Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery ± a fluoropyrimidine and surgery + a fluoropyrimidine ± oxaliplatin. Eur J Surg Oncol. 2015; 41(6): 713–723.
  30. Papamichael D, Audisio RA, Glimelius B, et al. Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann Oncol. 2015; 26(3): 463–476.

Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory